medical devices and innovations
-
Seychelles and Eritrea adopt Abbott’s triple elimination test for maternal health
Abbott’s Determine™ ANC Panel enables simultaneous detection of HIV, syphilis, and hepatitis B from a single finger-prick sample, delivering results within minutes at the point of care.
-
WellSpan Health chooses Philips Imaging Platforms for 12 regional hospitals
The alliance positions WellSpan as a key innovation partner for Philips, enabling the two institutions to co-develop and validate new digital health tools in real-world clinical environments.
-
Moscow’s MosMedAI launches 18th medical AI tool to automate scoliosis detection
The newly introduced AI algorithm performs measurements that radiologists previously conducted manually, significantly reducing interpretation time and improving consistency in diagnosis.
-
WHO donates US$331,000 worth of medical equipment to improve maternal and women’s cancer care in Kenya
The donation includes 108 electric obstetric theatre beds, along with specialised equipment for women’s cancer screening, diagnosis, and treatment.
-
Russia expands MosMedAI nationwide as computer vision analyzes 35M medical studies
Since 2020, the Moscow government has been running the Moscow Experiment on Computer Vision in healthcare, an initiative coordinated by the Center for Diagnostics and Telemedicine with support from the city’s digital infrastructure teams.
-
Roche accelerates development of rapid PCR test for Ebola Bundibugyo virus
The Bundibugyo strain remains particularly challenging because no approved vaccine or specific treatment is currently available.
-
Abbott secures CE mark for world’s first glucose-ketone wearable
The approval strengthens Abbott’s position in the continuous glucose monitoring (CGM) market and expands its diagnostic capabilities beyond glucose-only tracking, which has traditionally defined wearable diabetes management tools.
-
Philips unveils SmartIQ AI coronary imaging platform for Azurion at EuroPCR 2026
SmartIQ was developed in collaboration with leading cardiovascular centers to tackle one of the most persistent challenges in coronary imaging: balancing high-quality images with lower radiation exposure for both patients and healthcare professionals.
-
Oman launches the “Rased” smart disease surveillance platform to improve outbreak prediction
The newly introduced National Strategy for Vector Surveillance reflects Oman’s commitment to strengthening health security in line with Oman Vision 2040.
-
Oman Investment Authority invests in Neuralink as Brain-Computer Interface trials progress
Neuralink’s clinical programme has recorded notable early milestones, including reports that its first human participant successfully operated a computer and typed using neural signals alone.